$99.67
Value $79.9B
CL and PG stock compared: price, dividend, valuation and results, from SEC filings.
Colgate-Palmolive (CL) has a market value of $79.9B and Procter & Gamble (PG) $395B. Over the last year, with dividends, CL moved +29.9% and PG +18.0%. The P/E is 38.9 for CL and 25.1 for PG. Dividend yield: CL 2.12%, PG 2.55%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CL$79.9B
PG$395B
PG is 4.9 times CL
Revenue, 12 months
CL$21.3B
PG$87.9B
PG is 4.1 times CL
Net income, 12 months
CL$2.1B
PG$16.0B
PG is 7.8 times CL
Operating margin
CL14.8%
PG22.6%
7.8 points apart
ROIC
CL27.4%
PG17.3%
10.1 points apart
P/E
CL38.9
PG25.1
CL is 1.6 times PG
Dividend yield
CL2.1%
PG2.6%
0.5 points apart
5-year return
CL+43.8%
PG+31.8%
12.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CL+43.8%
PG+31.8%
| Period | CLWith dividends | PGWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +29.9%Price +26.9% | +18.0%Price +14.7% |
| 3 years since November 13, 2023 | +40.6%+12.0% a yearPrice +31.2% | +20.5%+6.4% a yearPrice +11.4% |
| 5 years since November 12, 2021 | +43.8%+7.5% a yearPrice +27.7% | +31.8%+5.7% a yearPrice +15.9% |
| 10 years since November 14, 2016 | +89.5%+6.6% a yearPrice +49.7% | +168.5%+10.4% a yearPrice +104.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CLColgate-PalmolivePGProcter & Gamble
| Price | $99.67 | $169.80 |
|---|---|---|
| Market value | $79.9B | $395B |
| Enterprise value (EV) | $85.5B | $418B |
| P/E | 38.9 | 25.1 |
| P/E, 5-year median | 30.1 | 24.8 |
| P/B | 277.4 | 7.2 |
| EV/EBIT | 27.1 | 21.1 |
| Free cash flow yield | 4.7% | 3.9% |
| Revenue, 12 months | $21.3B | $87.9B |
|---|---|---|
| Net income, 12 months | $2.1B | $16.0B |
| Free cash flow, 12 months | $3.8B | $15.3B |
| Earnings per share, 12 months | $2.56 | $6.64 |
| Revenue growth, year on year | 1.4% | 3.3% |
| Revenue growth a year, past | +4.4%over 5 years | +2.7%over 5 years |
| EPS growth a year, past | -3.5%over 5 years | +3.8%over 5 years |
| Gross margin | 60.6% | 49.8% |
|---|---|---|
| Operating margin | 14.8% | 22.6% |
| Net margin | 9.7% | 18.2% |
| ROIC | 27.4% | 17.3% |
| ROE | 650.4% | 29.5% |
| Cash | $1.5B | $15.4B |
|---|---|---|
| Total debt | $7.2B | $38.9B |
| Net debt / EBITDA | 1.5 | 1.0 |
| Interest cover | 12.7× | 22.0× |
| Dividend yield | 2.1% | 2.6% |
|---|---|---|
| Dividend per share, 12 months | $2.11 | $4.32 |
| Dividend growth a year, past | +3.5%over 5 years | +5.6%over 5 years |
| Buyback yield | 1.5% | 1.3% |
| Shareholder yield | 3.6% | 3.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Procter & Gamble ($395B) is about 4.9 times Colgate-Palmolive ($79.9B), at today's prices.
Since November 14, 2016, CL's price moved +49.7% and PG's +104.6%. With dividends: CL +89.5% (+6.6% a year), PG +168.5% (+10.4% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.12% for Colgate-Palmolive and 2.55% for Procter & Gamble. Over the last twelve months they paid $2.11 and $4.32 per share.
At today's price, the P/E is 38.9 for CL and 25.1 for PG. The median of the last five years was 30.1 and 24.8, which shows where each stands against its own past.
Over the last twelve months, the net margin was 9.7% for Colgate-Palmolive and 18.2% for Procter & Gamble, and the operating margin 14.8% and 22.6%. Revenue was $21.3B and $87.9B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.